InvestorsHub Logo

johnhancoque

12/02/23 1:06 PM

#418524 RE: sts66 #418523

Right! It's just wishful thinking. After sarissa took over there won't be much left of anything soon enough. No viable options. Sit and wait for $10 or 0 not much choice.

JRoon71

12/02/23 1:46 PM

#418526 RE: sts66 #418523

I still truly believe that Amarin already did this quietly. There's no way they didn't test/analyze them.

And based on the fact that they have said absolutely nothing about generic bio-equivalency, and refuse to even answer question about it, leads me to believe that they know the answer, but don't want it to become known. They would rather people like us continue to question the generics, rather than come out and say "yeah, we had them tested, and the ingredients would pass the FDA sniff-test".